UPDATE: UBS Investment Research Raises Target to $42 on Quality Systems
UBS Investment Research reiterates its Neutral rating on Quality Systems (NASDAQ: QSII) and raises its price target to $42 from $39 on bullish tone from the management.
UBS Investment Research says, "We hosted Quality Systems at the 2012 UBS Global Healthcare Services Conference today. CEO / President Steven Plochocki discussed QSII's market opportunity, which he believes has yet to peak, an improving pipeline and positive re-seller trends. Overall, mgmt sounded bullish on the near term opportunity."
QSII closed at $42.57 a share on Tuesday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.